Arena Pharmaceuticals (ARNA) and United Therapeutics (UTHR) announced on Nov. 15 that the two companies have reached a deal on the pulmonary arterial hypertension (PAH) drug Ralinepag. The $1.2 billion deal is the type of deal that many Arena investors have anticipated.
{iframe}https://seekingalpha.com/article/4222752-arena-inks-1_2-billion-deal-united-therapeutics{/iframe}